| Total | Alive | Dead | P |
---|---|---|---|---|
 | 42 | 11 | 31 | |
Sex (%) | Â | Â | Â | Â |
1 | 25 (59.52) | 6 (54.55) | 19 (61.29) | 0.9728 |
2 | 17 (40.48) | 5 (45.45) | 12 (38.71) | Â |
Age (%) | Â | Â | Â | Â |
≤ 12 months | 22 (52.38) | 3 (27.27) | 19 (61.29) | 0.112 |
> 12 months | 20 (47.62) | 8 (72.73) | 12 (38.71) |  |
Metastasis at diagnosis (%) | Â | Â | Â | Â |
No | 33 (78.57) | 11 (100.00) | 22 (70.97) | 0.1122 |
Yes | 9 (21.43) | 0 (0.00) | 9 (29.03) | Â |
Fever (%) | Â | Â | Â | Â |
No | 31 (73.81) | 9 (81.82) | 22 (70.97) | 0.7611 |
Yes | 11 (26.19) | 2 (18.18) | 9 (29.03) | Â |
Anemia (%) | Â | Â | Â | Â |
No | 28 (66.67) | 11 (100.00) | 17 (54.84) | 0.0184 |
Yes | 14 (33.33) | 0 (0.00) | 14 (45.16) | Â |
Hematuresis (%) | Â | Â | Â | Â |
No | 27 (64.29) | 7 (63.64) | 20 (64.52) | 1 |
Yes | 15 (35.71) | 4 (36.36) | 11 (35.48) | Â |
Hypertension (%) | Â | Â | Â | Â |
No | 38 (90.48) | 10 (90.91) | 28 (90.32) | 1 |
Yes | 4 (9.52) | 1 (9.09) | 3 (9.68) | Â |
Hypercalcemia (%) | Â | Â | Â | Â |
No | 38 (90.48) | 11 (100.00) | 27 (87.10) | 0.5127 |
Yes | 4 (9.52) | 0 (0.00) | 4 (12.90) | Â |
Preoperative chemotherapy (%) | Â | Â | Â | Â |
No | 33 (78.57) | 10 (90.91) | 23 (74.19) | 0.4635 |
Yes | 9 (21.43) | 1 (9.09) | 8 (25.81) | Â |
Tumor size (mean (SD)) | 9.112 (3.908) | 8.518 (4.622) | 9.323 (3.684) | 0.564 |
Operation time (mean (SD)) | 115.071 (34.384) | 121.273 (37.227) | 112.871 (33.686) | 0.4931 |
Hemorrhage (median [IQR]) | 70 [20, 200] | 35 [20, 110] | 100[35, 200] | 0.172 |
Tumor location (%) | Â | Â | Â | Â |
Full | 9 (21.43) | 1 (9.09) | 8 (25.81) | 0.0131 |
Upper | 16 (38.10) | 5 (45.45) | 11 (35.48) | Â |
Middle | 14 (33.33) | 2 (18.18) | 12 (38.71) | Â |
Lower | 3 (7.14) | 3 (27.27) | 0 (0.00) | Â |
Tumor side (%) | Â | Â | Â | Â |
Left | 22 (52.38) | 7 (63.64) | 15 (48.39) | 0.604 |
Right | 20 (47.62) | 4 (36.36) | 16 (51.61) | Â |
Cross the center line (%) | Â | Â | Â | Â |
No | 21 (50.00) | 4 (36.36) | 17 (54.84) | 0.4827 |
Yes | 21 (50.00) | 7 (63.64) | 14 (45.16) | Â |
Tumor rupture (%) | Â | Â | Â | Â |
No | 27 (64.29) | 8 (72.73) | 19 (61.29) | 0.7536 |
Yes | 15 (35.71) | 3 (27.27) | 12 (38.71) | Â |
Capsule (%) | Â | Â | Â | Â |
No | 19 (45.24) | 8 (72.73) | 11 (35.48) | 0.0751 |
Yes | 23 (54.76) | 3 (27.27) | 20 (64.52) | Â |
Incomplete tumor resection (%) | Â | Â | Â | Â |
No | 36 (85.71) | 11 (100.00) | 25 (80.65) | 0.2826 |
Yes | 6 (14.29) | 0 (0.00) | 6 (19.35) | Â |
Tumor embolus (%) | Â | Â | Â | Â |
No | 34 (80.95) | 9 (81.82) | 25 (80.65) | 1 |
Yes | 8 (19.05) | 2 (18.18) | 6 (19.35) | Â |
Infiltration (%) | Â | Â | Â | Â |
No | 30 (71.43) | 9 (81.82) | 21 (67.74) | 0.6175 |
Yes | 12 (28.57) | 2 (18.18) | 10 (32.26) | Â |
Lymph node metastasis (%) | Â | Â | Â | Â |
No | 37 (88.10) | 11 (100.00) | 26 (83.87) | 0.3803 |
Yes | 5 (11.90) | 0 (0.00) | 5 (16.13) | Â |
Tumor stage (%) | Â | Â | Â | Â |
I | 6 (14.29) | 4 (36.36) | 2 (6.45) | 0.0269 |
II | 5 (11.90) | 2 (18.18) | 3 (9.68) | Â |
III | 21 (50.00) | 5 (45.45) | 16 (51.61) | Â |
IV | 10 (23.81) | 0 (0.00) | 10 (32.26) | Â |
Preoperative chemotherapy (%) | Â | Â | Â | Â |
No | 30 (71.43) | 9 (81.82) | 21 (67.74) | 0.6175 |
Yes | 12 (28.57) | 2 (18.18) | 10 (32.26) | Â |
Chemotherapy protocol (%) | Â | Â | Â | Â |
No | 12 (28.57) | 2 (18.18) | 10 (32.26) | 0.6743 |
VDACE | 10 (23.81) | 3 (27.27) | 7 (22.58) | Â |
HU-1 | 20 (47.62) | 6 (54.55) | 14 (45.16) | Â |
Preoperative metastasis (%) | Â | Â | Â | Â |
No | 18 (42.86) | 11 (100.00) | 7 (22.58) | < 0.0001 |
Yes | 24 (57.14) | 0 (0.00) | 24 (77.42) | Â |